99 related articles for article (PubMed ID: 2126049)
1. In vitro augmentation of macrophage-activating-factor release from peripheral blood cells of cancer patients by a DNA fraction from Mycobacterium bovis BCG.
Mashiba H; Matsunaga K; Tomoda H; Furusawa M
Jpn J Med Sci Biol; 1990 Aug; 43(4):133-9. PubMed ID: 2126049
[TBL] [Abstract][Full Text] [Related]
2. In vitro augmentation of natural killer activity of peripheral blood cells from cancer patients by a DNA fraction from Mycobacterium bovis BCG.
Mashiba H; Matsunaga K; Tomoda H; Furusawa M; Jimi S; Tokunaga T
Jpn J Med Sci Biol; 1988; 41(5-6):197-202. PubMed ID: 3076601
[TBL] [Abstract][Full Text] [Related]
3. In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG.
Yamamoto S; Kuramoto E; Shimada S; Tokunaga T
Jpn J Cancer Res; 1988 Jul; 79(7):866-73. PubMed ID: 2459094
[TBL] [Abstract][Full Text] [Related]
4. DNA from Mycobacterium bovis bacillus Calmette-Guérin (MY-1) inhibits immunoglobulin E production by human lymphocytes.
Fujieda S; Iho S; Kimura Y; Sunaga H; Igawa H; Sugimoto C; Yamamoto S; Saito H
Am J Respir Crit Care Med; 1999 Dec; 160(6):2056-61. PubMed ID: 10588628
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
[TBL] [Abstract][Full Text] [Related]
6. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
Lee JC; Rebar L; Young P; Ruscetti FW; Hanna N; Poste G
J Immunol; 1986 Feb; 136(4):1322-8. PubMed ID: 3003193
[TBL] [Abstract][Full Text] [Related]
8. Biological and biochemical characterization of macrophage activating factor (MAF) in murine lymphocytes: physiocochemical similarity of MAF to gamma interferon (IFN-gamma).
Fukazawa Y; Kagaya K; Miura H; Shinoda T; Natori K; Yamazaki S
Microbiol Immunol; 1984; 28(6):691-702. PubMed ID: 6434908
[TBL] [Abstract][Full Text] [Related]
9. Human macrophage-activating factors for cytotoxicity. I. Establishment of a human T-cell hybridoma that produces macrophage-activating factors for cytotoxicity.
Higuchi M; Sugimoto M; Kobayashi Y; Osawa T
Microbiol Immunol; 1987; 31(5):469-79. PubMed ID: 3116371
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activating factor is not identical with immune interferon or a factor inducing differentiation of mouse myeloid leukemic cells.
Yamamoto Y; Tomida M; Hozumi M
Gan; 1982 Aug; 73(4):557-64. PubMed ID: 6818089
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
[TBL] [Abstract][Full Text] [Related]
12. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
Nathan CF; Murray HW; Wiebe ME; Rubin BY
J Exp Med; 1983 Sep; 158(3):670-89. PubMed ID: 6411853
[TBL] [Abstract][Full Text] [Related]
13. Ability of T cell subsets and their soluble mediators to modulate the replication of Mycobacterium bovis in bovine macrophages.
Denis M; Wedlock DN; Buddle BM
Cell Immunol; 2004; 232(1-2):1-8. PubMed ID: 15922710
[TBL] [Abstract][Full Text] [Related]
14. Functional identity between murine gamma interferon and macrophage activating factor.
Schultz RM; Kleinschmidt WJ
Nature; 1983 Sep 15-21; 305(5931):239-40. PubMed ID: 6412144
[TBL] [Abstract][Full Text] [Related]
15. Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.
Svedersky LP; Benton CV; Berger WH; Rinderknecht E; Harkins RN; Palladino MA
J Exp Med; 1984 Mar; 159(3):812-27. PubMed ID: 6421982
[TBL] [Abstract][Full Text] [Related]
16. [Commemorative lecture of receiving Imamura Memorial Prize. II. Mode of action of oligonucleotide fraction extracted from Mycobacterium bovis BCG].
Yamamoto S
Kekkaku; 1994 Sep; 69(9):571-4. PubMed ID: 7526022
[TBL] [Abstract][Full Text] [Related]
17. IFN-gamma enhances bovine macrophage responsiveness to Mycobacterium bovis: Impact on bacterial replication, cytokine release and macrophage apoptosis.
Denis M; Wedlock DN; Buddle BM
Immunol Cell Biol; 2005 Dec; 83(6):643-50. PubMed ID: 16266317
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
Celada A; Gray PW; Rinderknecht E; Schreiber RD
J Exp Med; 1984 Jul; 160(1):55-74. PubMed ID: 6330272
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium bovis Δmce2 double deletion mutant protects cattle against challenge with virulent M. bovis.
Blanco FC; Bianco MV; Garbaccio S; Meikle V; Gravisaco MJ; Montenegro V; Alfonseca E; Singh M; Barandiaran S; Canal A; Vagnoni L; Buddle BM; Bigi F; Cataldi A
Tuberculosis (Edinb); 2013 May; 93(3):363-72. PubMed ID: 23518075
[TBL] [Abstract][Full Text] [Related]
20. Bovine natural killer cells restrict the replication of Mycobacterium bovis in bovine macrophages and enhance IL-12 release by infected macrophages.
Denis M; Keen DL; Parlane NA; Storset AK; Buddle BM
Tuberculosis (Edinb); 2007 Jan; 87(1):53-62. PubMed ID: 16730232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
